For clinical relevance and brevity, we will mainly focus on gaps in current knowledge on how semaglutide alters molecular mechanisms, especially in adipose tissue and skeletal muscle, and how it interacts with leptin, adipokines and myokines, enlightening possible benefits in the aging process and inflammation
Diabetes Spectrum 19(1):4349
The safety differentiator right now is the OpenLoop breach exposure
Nevertheless, patients would continue to use it, above all if severe symptoms are present
The post says GLP-1 medications slow gastric emptying, which could theoretically affect the absorption timing of levothyroxine and in turn TSH stability
Research use statement AlphaGen does not provide dosing advice, administration guidance, treatment recommendations, or therapeutic instructions